Your browser doesn't support javascript.
loading
Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome.
Garelius, H K G; Johnston, W T; Smith, A G; Park, S; de Swart, L; Fenaux, P; Symeonidis, A; Sanz, G; Cermák, J; Stauder, R; Malcovati, L; Mittelman, M; van de Loosdrecht, A A; van Marrewijk, C J; Bowen, D; Crouch, S; de Witte, T J M; Hellström-Lindberg, E.
Affiliation
  • Garelius HK; Department of Medicine, Section of Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Johnston WT; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK.
  • Smith AG; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK.
  • Park S; Clinique Universitaire d'hématologie, CHU de Grenoble, Université Grenoble, Grenoble, France.
  • de Swart L; Department of Hematology, Radboud university medical center, Nijmegen, the Netherlands.
  • Fenaux P; Service d'Hématologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP) and Université Paris 7, Paris, France.
  • Symeonidis A; Department of Medicine, Division of Hematology, University of Patras Medical School, Patras, Greece.
  • Sanz G; Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Cermák J; Department of Clinical Hematology, Institute of Hematology & Blood Transfusion, Praha, Czech Republic.
  • Stauder R; Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria.
  • Malcovati L; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
  • Mittelman M; Department of Medicine A, Tel Aviv Sourasky (Ichilov) Medical Center, Tel Aviv, Israel.
  • van de Loosdrecht AA; Department of Hematology, VU Institute of Cancer and Immunology, VU University Medical Center, Amsterdam, the Netherlands.
  • van Marrewijk CJ; Department of Hematology, Radboud university medical center, Nijmegen, the Netherlands.
  • Bowen D; St. James's Institute of Oncology, Leeds Teaching Hospitals, Leeds, UK.
  • Crouch S; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK.
  • de Witte TJ; Department of Tumor Immunology, Nijmegen Center for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands.
  • Hellström-Lindberg E; Department of Medicine, Division of Hematology, Karolinska Institutet, Stockholm, Sweden.
J Intern Med ; 281(3): 284-299, 2017 03.
Article in En | MEDLINE | ID: mdl-27926979
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Transfusion / Myelodysplastic Syndromes / Hematinics Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Intern Med Journal subject: MEDICINA INTERNA Year: 2017 Type: Article Affiliation country: Sweden
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Transfusion / Myelodysplastic Syndromes / Hematinics Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Intern Med Journal subject: MEDICINA INTERNA Year: 2017 Type: Article Affiliation country: Sweden